Issues regarding the reimbursement of radiopharmaceuticals Facilitating Innovative Nuclear Diagnostics Act of 2023
2025 · 1st Quarter (Jan 1 - Mar 31)
COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS
Filed by ALPINE GROUP PARTNERS, LLC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 8, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ALPINE GROUP PARTNERS, LLC.
- Filing UUID
- 00c9c5f1-a436-4d84-afb3-7d4aa52d4066
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues regarding the reimbursement of radiopharmaceuticals Facilitating Innovative Nuclear Diagnostics Act of 2023
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.